The GCE Zen-O portable oxygen concentrator is designed to enable patients with respiratory disorders to better manage their oxygen therapy.

Weighing just 4.66 kg the Zen-O can deliver up to 2l/ minute of oxygen in either pulse or continuous flow and is supplied with variety of accessories, including a carry bag and a pull cart for increased mobility.

Zen-O is designed with easy-to-replace sieve bed. The sieve bed can be replaced in the field using simple tools in under five minutes, saving time and money. Zen-O is manufactured in the UK.

Zen-O portable oxygen concentrator can deliver up to 2 litres of oxygen in either pulse or
continuous flow.

Stockists: The Oxygen Store, Intermedical Homecare.

Antimuscarinic bronchodilator.

For the treatment of excessive respiratory secretions in palliative care by subcutaneous injection
Adult: 200 mcg every 4 hours and when required, hourly use is occasionally necessary, particularly in excessive respiratory secretions.

For the treatment of excessive respiratory secretions in palliative care by subcutaneous infusion
Adult: 0.6–1.2 mg/24 hours.

Antimuscarinic bronchodilator.

In the case of excessive respiratory secretions in palliative care by subcutaneous injection
Adult: 200 micrograms every 4 hours and when required, hourly use is occasionally necessary.

In the case of excessive respiratory secretions in palliative care by subcutaneous infusion
Adult: 0.6–1.2 mg/24 hours.

Antimuscarinic bronchodilator.

For the treatment of excessive respiratory secretions in palliative care by subcutaneous injection
Adult: 200 mcg every 4 hours and when required, hourly use is occasionally necessary, particularly in excessive respiratory secretions.

For the treatment of excessive respiratory secretions in palliative care by subcutaneous infusion
Adult: 0.6–1.2 mg/24 hours.

Antimuscarinic bronchodilator.

For the treatment of excessive respiratory secretions in palliative care by subcutaneous injection
Adult: 200 mcg every 4 hours and when required, hourly use is occasionally necessary, particularly in excessive respiratory secretions.

For the treatment of excessive respiratory secretions in palliative care by subcutaneous infusion
Adult: 0.6–1.2 mg/24 hours.

Antimuscarinic bronchodilator.

For the treatment of excessive respiratory secretions in palliative care by subcutaneous injection
Adult: 200 mcg every 4 hours and when required, hourly use is occasionally necessary, particularly in excessive respiratory secretions.

For the treatment of excessive respiratory secretions in palliative care by subcutaneous infusion
Adult: 0.6–1.2 mg/24 hours.

Antimuscarinic bronchodilator.

For the treatment of excessive respiratory secretions in palliative care by subcutaneous injection
Adult: 200 mcg every 4 hours and when required, hourly use is occasionally necessary, particularly in excessive respiratory secretions.

For the treatment of excessive respiratory secretions in palliative care by subcutaneous infusion
Adult: 0.6–1.2 mg/24 hours.

Antimuscarinic bronchodilator.

For excessive respiratory secretions in palliative care by subcutaneous injection
Adult: 200 mcg every 4 hours and when required, hourly use is occasionally necessary, particularly in excessive respiratory secretions.
By subcutaneous infusion
Adult: 0.6–1.2 mg/24 hours.

for maintenance treatment of chronic obstructive pulmonary disease by inhalation of powder
Adult: 1 capsule once daily, each capsule delivers 55 mcg of glycopyrronium bromide (equivalent to 44 mcg of glycopyrronium).